.jpg)
.jpg)
.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Life expectancy in New York City has been falling. A new plan to address it incl...
A ruling may come this month on UnitedHealth's motion to dismiss a lawsuit stemm...
The Howard Hughes Medical Institute abruptly ended a $60 million program to impr...
Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if...
This week in health care policy and politics: Analyzing MAHA, the White House's ...
Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or...
Anaesthetics are not putting patients to sleep, doctors warn, in call for greate...
Pharma groups say higher levy will stifle growth of life sciences
Panel grills Donald Trump’s nominee for top health post on abortion stance and ‘...
Decision is a blow to Starmer’s government after setting out pro-growth pitch to...
UK company raised NHS rejection of its new breast cancer drug and drug pricing m...
Drugmaker pauses Gardasil exports to help ‘trusted partner’ reduce excess inventory
Albert Bourla says Donald Trump’s nominee for health secretary still appeared to...
UK pharma group raises long-term annual sales forecast to more than £40bn by 2031
Western drugmakers look to Chinese trials for early data on treatments’ potentia...
CVMP opinions on veterinary medicinal productsThe Committee adopted by consensus...
Medicines containing semaglutide: PRAC investigating risk of rare eye conditionP...
In 2024, EMA recommended 114 medicines for marketing authorisation. Of these, 46...
EMA has published the revised version of its policies on the handling of competi...
EMA is ready to support the implementation of the new regulation on health techn...
From today, all clinical trials in the European Union (EU), including ongoing tr...
Eight new medicines recommended for approvalEMA’s human medicines committee (CHM...